Publications: Ham, Kristin
Journal Article
Ham, K.A.
ORCID: 0000-0002-7036-5334, Aung-Htut, M.T., Fletcher, S. and Wilton, S.D.
(2020)
Nonsequential splicing events alter antisense-mediated exon skipping outcome in COL7A1.
International Journal of Molecular Sciences, 21
(20).
Article 7705.
Aung-Htut, M.T., Ham, K.A.ORCID: 0000-0002-7036-5334, Tchan, M.C., Fletcher, S. and Wilton, S.D.
(2020)
Novel mutations found in individuals with adult-onset Pompe disease.
Genes, 11
(2).
Article 135.
Aung-Htut, M.T., Ham, K.A.ORCID: 0000-0002-7036-5334, Tchan, M., Johnsen, R., Schnell, F.J., Fletcher, S. and Wilton, S.D.
(2020)
Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease.
Scientific Reports, 10
.
Article number: 6702.
Li, D., Aung-Htut, M.T., Ham, K.A.ORCID: 0000-0002-7036-5334, Fletcher, S. and Wilton, S.D.
(2020)
A splice intervention therapy for autosomal recessive juvenile Parkinson’s disease arising from Parkin mutations.
International Journal of Molecular Sciences, 21
(19).
Article 7282.
Aung-Htut, M.T., McIntosh, C.S., West, K.A.ORCID: 0000-0002-7036-5334, Fletcher, S. and Wilton, S.D.
(2019)
In vitro validation of phosphorodiamidate morpholino oligomers.
Molecules, 24
(16).
Article 2922.
Aung-Htut, M.T., McIntosh, C.S., Ham, K.A.ORCID: 0000-0002-7036-5334, Pitout, I.L., Flynn, L.L., Greer, K., Fletcher, S. and Wilton, S.D.
(2019)
Systematic approach to developing splice modulating antisense oligonucleotides.
International Journal of Molecular Sciences, 20
(20).
Article 5030.
Matthews, V., Candy, P.A., West, K.A.ORCID: 0000-0002-7036-5334, Knuckey, N.W., Robbins, P., Jeffcote, T. and Boulos, S.
(2018)
CYPA and CD147 expression analysis in human glioblastoma: Evidence for a correlation with reduced survival.
Journal of Translational Science, 4
(5).
pp. 1-7.
Greene, I.D., Mastaglia, F., Meloni, B.P., West, K.A.ORCID: 0000-0002-7036-5334, Chieng, J., Mitchell, C.J., Gai, W-P and Boulos, S.
(2013)
Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation.
Journal of Neuroscience Research, 92
(4).
pp. 506-516.